查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2024-2028年全球血型試劑市場
市場調查報告書
商品編碼
1462448

2024-2028年全球血型試劑市場

Global Blood-Grouping Reagents Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 172 Pages | 訂單完成後即時交付

價格

血型試劑市場預計在 2023-2028 年期間成長 5.2068 億美元，預測期內複合年成長率為 8.13%。

該報告包括對血型試劑市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由慢性病患病率上升、捐血增加以及醫院和血庫數量增加所推動的。

市場範圍
基準年 2024年
結束年份 2028年
預測期 2024-2028
成長動力 加速度
2024年與前一年同期比較 7.67%
複合年成長率 8.13%
增量 52068萬美元

研究認為，診斷設備的進步將成為未來幾年推動血型試劑市場成長的關鍵因素之一。此外，血型檢測中多重檢測的日益採用、自動化和高通量平台的整合將帶來巨大的市場需求。

目錄

第1章執行摘要

  • 市場概況

第2章 市場狀況

  • 市場生態系統

第3章 市場規模評估

  • 市場定義
  • 細分市場分析
  • 2023 年市場規模
  • 2023-2028年市場展望

第4章 市場規模表現

  • 2018-2022年全球血型試劑市場
  • 2018-2022 年最終用戶細分分析
  • 2018-2022年技術細分分析
  • 2018-2022 年區域細分分析
  • 2018-2022 年國家細分分析

第5章五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第 6 章市場區隔：按最終用戶

  • 細分市場
  • 比較：按最終用戶
  • 醫院和血庫：2023-2028 年市場規模和預測
  • 臨床實驗室：2023-2028 年市場規模及預測
  • 學術研究院：2023-2028年市場規模及預測
  • 市場機會：依最終用戶分類

第7章市場區隔：依技術

  • 細分市場
  • 比較：按技術
  • 基於 PCR 和微陣列技術：2023-2028 年市場規模和預測
  • 基於檢測的技術：2023-2028 年市場規模與預測
  • 大規模定序技術：2023-2028年市場規模及預測
  • 血清學：2023-2028 年市場規模與預測
  • 市場機會：依技術分類

第8章 客戶狀況

  • 客戶狀況概覽

第9章 地區情勢

  • 區域細分
  • 區域比較
  • 北美：2023-2028 年市場規模與預測
  • 歐洲：2023-2028 年市場規模與預測
  • 亞洲：2023-2028年市場規模與預測
  • 世界其他地區：2023-2028 年市場規模與預測
  • 美國：2023-2028 年市場規模與預測
  • 英國：2023-2028 年市場規模與預測
  • 加拿大：2023-2028 年市場規模與預測
  • 法國：2023-2028年市場規模與預測
  • 日本：2023-2028年市場規模與預測
  • 市場機會：依地區狀況

第 10 章 促進因素、挑戰與趨勢

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場趨勢

第11章 供應商情況

  • 概述
  • 供應商情況
  • 混亂的情況
  • 產業風險

第12章供應商分析

  • 交易廠商
  • 供應商市場定位
  • AliveDX
  • Arena Bio Scien
  • ARKRAY Inc.
  • Atlas Medical GmbH
  • Bio Rad Laboratories Inc.
  • Calibre Scientific Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Merck KGaA
  • Novacyt SA
  • Paragon Care Ltd.
  • QuidelOrtho Corp.
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics Pvt. Ltd.

第13章附錄

Product Code: IRTNTR40141

The blood-grouping reagents market is forecasted to grow by USD 520.68 mn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and a growing number of hospitals and blood banks.

Technavio's blood-grouping reagents market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.67%
CAGR8.13%
Incremental Value$520.68mn

By End-user

  • Hospitals and blood banks
  • Clinical laboratories
  • Academic and research institutes

By Technique

  • PCR-based and microarray techniques
  • Assay-based techniques
  • Massively parallel sequencing techniques
  • Serology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advancements in diagnostic devices as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, the growing adoption of multiplexing assays and integration of automation and high-throughput platforms in blood grouping will lead to sizable demand in the market.

The report on the blood-grouping reagents market covers the following areas:

  • Blood-grouping reagents market sizing
  • Blood-grouping reagents market forecast
  • Blood-grouping reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global blood-grouping reagents market 2018 - 2022
  • 4.2 End-User Segment Analysis 2018 - 2022
  • 4.3 Technique Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022
  • 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by End-user

  • 6.1 Market segments
  • 6.2 Comparison by End-user
  • 6.3 Hospitals and blood banks - Market size and forecast 2023-2028
  • 6.4 Clinical laboratories - Market size and forecast 2023-2028
  • 6.5 Academic and research institutes - Market size and forecast 2023-2028
  • 6.6 Market opportunity by End-user

7 Market Segmentation by Technique

  • 7.1 Market segments
  • 7.2 Comparison by Technique
  • 7.3 PCR-based and microarray techniques - Market size and forecast 2023-2028
  • 7.4 Assay-based techniques - Market size and forecast 2023-2028
  • 7.5 Massively parallel sequencing techniques - Market size and forecast 2023-2028
  • 7.6 Serology - Market size and forecast 2023-2028
  • 7.7 Market opportunity by Technique

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 UK - Market size and forecast 2023-2028
  • 9.9 Canada - Market size and forecast 2023-2028
  • 9.10 France - Market size and forecast 2023-2028
  • 9.11 Japan - Market size and forecast 2023-2028
  • 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 AliveDX
  • 12.4 Arena Bio Scien
  • 12.5 ARKRAY Inc.
  • 12.6 Atlas Medical GmbH
  • 12.7 Bio Rad Laboratories Inc.
  • 12.8 Calibre Scientific Inc.
  • 12.9 Danaher Corp.
  • 12.10 DIAGAST SAS
  • 12.11 Grifols SA
  • 12.12 Merck KGaA
  • 12.13 Novacyt SA
  • 12.14 Paragon Care Ltd.
  • 12.15 QuidelOrtho Corp.
  • 12.16 Thermo Fisher Scientific Inc.
  • 12.17 Tulip Diagnostics Pvt. Ltd.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by End-user ($ million)
  • Exhibits47: Data Table on Market opportunity by End-user ($ million)
  • Exhibits48: Chart on Technique - Market share 2023-2028 (%)
  • Exhibits49: Data Table on Technique - Market share 2023-2028 (%)
  • Exhibits50: Chart on Comparison by Technique
  • Exhibits51: Data Table on Comparison by Technique
  • Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
  • Exhibits65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
  • Exhibits66: Chart on Serology - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Market opportunity by Technique ($ million)
  • Exhibits69: Data Table on Market opportunity by Technique ($ million)
  • Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits73: Chart on Geographic comparison
  • Exhibits74: Data Table on Geographic comparison
  • Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits111: Market opportunity By Geographical Landscape ($ million)
  • Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits113: Impact of drivers and challenges in 2023 and 2028
  • Exhibits114: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits115: Overview on factors of disruption
  • Exhibits116: Impact of key risks on business
  • Exhibits117: Vendors covered
  • Exhibits118: Matrix on vendor position and classification
  • Exhibits119: AliveDX - Overview
  • Exhibits120: AliveDX - Product / Service
  • Exhibits121: AliveDX - Key offerings
  • Exhibits122: Arena Bio Scien - Overview
  • Exhibits123: Arena Bio Scien - Product / Service
  • Exhibits124: Arena Bio Scien - Key offerings
  • Exhibits125: ARKRAY Inc. - Overview
  • Exhibits126: ARKRAY Inc. - Product / Service
  • Exhibits127: ARKRAY Inc. - Key offerings
  • Exhibits128: Atlas Medical GmbH - Overview
  • Exhibits129: Atlas Medical GmbH - Product / Service
  • Exhibits130: Atlas Medical GmbH - Key offerings
  • Exhibits131: Bio Rad Laboratories Inc. - Overview
  • Exhibits132: Bio Rad Laboratories Inc. - Business segments
  • Exhibits133: Bio Rad Laboratories Inc. - Key news
  • Exhibits134: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits135: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits136: Calibre Scientific Inc. - Overview
  • Exhibits137: Calibre Scientific Inc. - Product / Service
  • Exhibits138: Calibre Scientific Inc. - Key offerings
  • Exhibits139: Danaher Corp. - Overview
  • Exhibits140: Danaher Corp. - Business segments
  • Exhibits141: Danaher Corp. - Key news
  • Exhibits142: Danaher Corp. - Key offerings
  • Exhibits143: Danaher Corp. - Segment focus
  • Exhibits144: DIAGAST SAS - Overview
  • Exhibits145: DIAGAST SAS - Product / Service
  • Exhibits146: DIAGAST SAS - Key offerings
  • Exhibits147: Grifols SA - Overview
  • Exhibits148: Grifols SA - Business segments
  • Exhibits149: Grifols SA - Key offerings
  • Exhibits150: Grifols SA - Segment focus
  • Exhibits151: Merck KGaA - Overview
  • Exhibits152: Merck KGaA - Business segments
  • Exhibits153: Merck KGaA - Key news
  • Exhibits154: Merck KGaA - Key offerings
  • Exhibits155: Merck KGaA - Segment focus
  • Exhibits156: Novacyt SA - Overview
  • Exhibits157: Novacyt SA - Business segments
  • Exhibits158: Novacyt SA - Key offerings
  • Exhibits159: Novacyt SA - Segment focus
  • Exhibits160: Paragon Care Ltd. - Overview
  • Exhibits161: Paragon Care Ltd. - Business segments
  • Exhibits162: Paragon Care Ltd. - Key offerings
  • Exhibits163: Paragon Care Ltd. - Segment focus
  • Exhibits164: QuidelOrtho Corp. - Overview
  • Exhibits165: QuidelOrtho Corp. - Product / Service
  • Exhibits166: QuidelOrtho Corp. - Key offerings
  • Exhibits167: Thermo Fisher Scientific Inc. - Overview
  • Exhibits168: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits169: Thermo Fisher Scientific Inc. - Key news
  • Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits172: Tulip Diagnostics Pvt. Ltd. - Overview
  • Exhibits173: Tulip Diagnostics Pvt. Ltd. - Product / Service
  • Exhibits174: Tulip Diagnostics Pvt. Ltd. - Key offerings
  • Exhibits175: Inclusions checklist
  • Exhibits176: Exclusions checklist
  • Exhibits177: Currency conversion rates for US$
  • Exhibits178: Research methodology
  • Exhibits179: Validation techniques employed for market sizing
  • Exhibits180: Information sources
  • Exhibits181: List of abbreviations